News
Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer's disease (AD). TML-6 combines ...
Key companies, such as CSL Behring, Equillium, Biocon, and medac, are advancing their assets through late-stage graft versus host disease clinical trials, driving innovation in the graft versus host ...
Cancer Pain Market Key Insights 2. Cancer Pain Market Report Introduction 3. Cancer Pain Market Overview at a Glance ...
Women physicians were 60% more likely to say portal messages needed more clinical review and 76% more likely to cite them as ...
TikTok videos with informative and empowering messages may improve cervical cancer screening rates, especially among young ...
Despite the global shockwaves of COVID-19, wildlife markets long known to be high-risk environments for disease spillover ...
Research reveals that bat viruses similar to MERS (Middle East Respiratory Syndrome) have the potential to infect humans. ...
A promising gene therapy for Alzheimer's disease aims to protect the brain from damage and preserve cognitive function.
Unearthing the hidden history of leprosy in the Americas-tracing its ancient origins, evolution, and profound impact on ...
Stroke survivors with depression or anxiety who attend talking therapy sessions are more likely to recover from their ...
Creatine is more than a muscle-builder—it's safe, science-backed, and supports brain, muscle, and overall health across all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results